• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » SARS-CoV-2

Articles Tagged with ''SARS-CoV-2''

Herd immunity illustration

COVID-19: Trying for herd immunity without vaccine ‘unethical’ and ‘unachievable’

July 7, 2020
By Anette Breindl
A large epidemiological study published in the July 6, 2020, advance online issue of The Lancet found that most individuals who became infected with SARS-CoV-2 developed antibodies to the virus, confirming that infection usually results in at least a short-term immune response.
Read More

In the clinic for July 7, 2020

July 7, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cerus, Myriad, Natera.
Read More

Other news to note for July 7, 2020

July 7, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 7 Hills Pharma, Aboundbio, Akers, Allergan, Arca, Artisan Bio, Biothera, Byondis, Boehringer Ingelheim, Cabaletta Bio, Cage Bio, Cellenkos, Clarametyx, Cybin, Cytoagents, Daewoong, Editas, Evolus, Ferring, Hemostemix, Hepion, Hibercell, Innovation, Insmed, Intelgenx, Maia, Medytox, Mylan, Nasus, Nitto Denko, Numab, Pacgen Life Science, Predictive Oncology, Plakous, Prolynx, Rakuten, Regeneron, Reven, Quantitative Medicine, Tessera, Therapeutic Solutions, Theratechnologies, Tonix, Turning Point, UCB, Zai Lab.
Read More
Herd immunity illustration

COVID-19: Trying for herd immunity without vaccine ‘unethical’ and ‘unachievable’

July 6, 2020
By Anette Breindl
A large epidemiological study published in the July 6, 2020, advance online issue of The Lancet found that most individuals who became infected with SARS-CoV-2 developed antibodies to the virus, confirming that infection usually results in at least a short-term immune response.
Read More

Regulatory front for July 6, 2020

July 6, 2020
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: Aetna, Arrow International, BD, Erba Diagnostics, Eternity Healthcare.
Read More

Regulatory actions for July 6, 2020

July 6, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbott, BD, Centogene, Cochlear, Inmode.
Read More

BioWorld MedTech’s Cardiology Extra for July 6, 2020

July 6, 2020
By Liz Hollis and Anette Breindl
Keeping you up to date on recent developments in cardiology, including: Potassium channel distancing fights stroke; Examining ischemic stroke in patients with COVID-19 vs. those with influenza; COVID-19 infects heart cells in lab dish.
Read More

Other news to note for July 6, 2020

July 6, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adma, Aim, American Regent, ANI, Anixa, Applied, Ascentage, Bristol Myers Squibb, Connectyx, Curevac, Cytodyn, Dragonfly, Emergent, Entasis, Fusion, Gilead, Hemostemix, Hitgen, Immune Regulation, Janssen, Johnson & Johnson, Merck, Medivir, Morphic, MSD, Nyrada, Precision Biosciences, Theratechnologies, Tollys, Zealand.
Read More

In the clinic for July 6, 2020

July 6, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D, Adverum, Avrobio, Anavex, Bellus, Celixir, CSL, Deciphera, Gensight, Gilead, Idorsia, Immunomedics, Inventiva, Merck, Myovant, Obseva, Oryzon, Sunovion, Regeneron, Sanofi.
Read More
Coronavirus vaccine/therapeutics illustration

Taxpayer-enabled COVID-19 vaccines will cost less, but distribution system requires another at-risk investment

July 2, 2020
By Mark McCarty
The question of prices for a COVID-19 vaccine have raged in recent days. Gary Disbrow, acting director of the Biomedical Advanced Research and Development Authority (BARDA), told members of a Senate committee that vaccines developed with the help of taxpayer funding will come with an appropriate reduction in price. However, CDC Director Robert Redfield emphasized that the cold-chain distribution system for those products requires the same kind of at-risk investment that is used for vaccine development.
Read More
Previous 1 2 … 106 107 108 109 110 111 112 113 114 … 135 136 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 29, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 29, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 29, 2025
  • Illustration of Microglia cells (red) in Alzheimer´s disease

    Two cancer drugs combined modify Alzheimer’s disease in mice

    BioWorld
    Current treatments for Alzheimer’s disease have limited effects. While they can slow cognitive decline or alleviate symptoms, they do not reverse this complex...
  • Opportunity compass with Chinese flag

    For big pharma, China is a shopper’s dream

    BioWorld
    Big pharma is increasingly shopping in China to fill its pipelines as it faces looming patent cliffs on major blockbusters coupled with growing pricing...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe